Clinical Trials on Diminished Ovarian Reserve
Total 5110 results
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute, NaplesRecruitingLow-grade Serous Ovarian Carcinoma | Recurrent Invasive Borderline Serous Ovarian CancerItaly
-
Royal Surrey County Hospital NHS Foundation TrustUnknownOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Neoplasm | Ovarian Neoplasm EpithelialUnited Kingdom
-
Gradalis, Inc.CompletedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Massachusetts General HospitalTerminatedRecurrent Ovarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
University Hospital, GenevaEuropean Society for Blood and Marrow TransplantationRecruitingChildren Who Receive a Stem Cell Transplantation With Busulfan IVCanada, France, Switzerland
-
St. Louis Joint Replacement InstituteUnknownReverse or Primary Total Shoulder | Rotator Cuff- Full Thickness- RepairUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Ovarian Carcinoma | Ovarian Serous TumorUnited States
-
Stanford UniversityCompletedOvarian Failure, PrematureUnited States
-
University of LiegeCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian CarcinomaUnited States
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Catholic University of the Sacred HeartCompletedStage IIIC Ovarian CancerItaly
-
Institut CurieARCAGY/ GINECO GROUPCompletedBorderline Ovarian TumorsFrance
-
Cengiz Gokcek Women's and Children's HospitalCompletedPremature Ovarian FailureTurkey
-
Sichuan Cancer Hospital and Research InstituteUnknownAngiogenesis Inhibitors，Ovarian NeoplasmsChina
-
Etlik Zubeyde Hanim Womens' Health and Teaching...CompletedOvarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.RecruitingAdvanced Ovarian CancerChina
-
Japanese Gynecologic Oncology GroupKorean Gynecologic Oncology GroupRecruitingEpithelial Ovarian CancerJapan, Korea, Republic of
-
Tesaro, Inc.Completed
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruiting
-
Baylor Research InstituteActive, not recruitingEpithelial Ovarian CancerUnited States
-
MorphotekTerminatedEpithelial Ovarian CancerUnited States, Germany
-
PharmaMarCompletedRelapsed Ovarian CancerSpain, France, Italy, Belgium, Germany
-
Universitaire Ziekenhuizen KU LeuvenAstraZenecaActive, not recruitingOvarian Epithelial CancerBelgium
-
Chang Gung Memorial HospitalHoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology...CompletedEpithelial Ovarian CancerTaiwan
-
Immetacyte LtdWithdrawnOvarian Cancer MetastaticUnited Kingdom
-
Qianfoshan HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.UnknownImmune Checkpoint InhibitionChina
-
Splash Pharmaceuticals, Inc.UnknownOvarian Epithelial CancerUnited States
-
Assiut UniversityUnknown
-
Dr Thumuluru Kavitha MadhuriCompletedEpithelial Ovarian CancerUnited Kingdom
-
Verastem, Inc.Terminated
-
Allife Medical Science and Technology Co., Ltd.UnknownEpithelial Ovarian Cancer
-
University of California, DavisNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Yonsei UniversityCompletedAdvanced-stage Ovarian CancerKorea, Republic of
-
EMD SeronoWithdrawn
-
Inge Marie SvaneCompleted
-
Sunesis PharmaceuticalsCompletedEpithelial Ovarian CancerUnited States, Canada
-
Gynecologic Oncology AssociatesUniversity of North Carolina, Chapel HillUnknownEpithelial Ovarian CarcinomaUnited States
-
Prima BioMed LtdTerminatedEpithelial Ovarian CancerUnited States, Australia
-
SOTIO a.s.TerminatedEpithelial Ovarian CarcinomaGermany, Poland, Czech Republic
-
University of UtahCompletedSurgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to StandEpithelial Ovarian CancerUnited States
-
Vanderbilt UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedOvarian CancerUnited States
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Assistance Publique - Hôpitaux de ParisTerminatedOvarian Cancer | RelapsesFrance